Epigenomics and single cell CRISPR screening to investigate the risk‐modifying role of microglia in Alzheimer’s disease and multiple sclerosis
Michael D Gallagher, Wenjuan Du, Katheryn EA Hazel, Zeynep Aydin, Yiran Cheng, Bingbing Yuan, George W Bell, Richard A Young, Rudolf Jaenisch, Olivia Corradin · 2025
Read Epigenomics and single cell CRISPR screening to investigate the risk‐modifying role of microglia in Alzheimer’s disease and multiple sclerosis by Michael D Gallagher, Wenjuan Du, Katheryn EA Hazel, Zeynep Aydin, Yiran Cheng, Bingbing Yuan, George W Bell, Richard A Young, Rudolf Jaenisch, Olivia Corradin (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11710746.txt.
Description
Michael D Gallagher and co-authors report a 2025 study of gene risk for Alzheimer's disease and multiple sclerosis. Gene scans have found hundreds of risk spots, but most sit outside genes, in DNA that acts in one cell type only. The team grew brain cells from stem cells and mapped the active DNA in each type.
Cells grown in the lab matched real human brain cells in their active DNA patterns. Microglia, the brain's immune cells, matched best, and risk spots clustered in their active zones. The team then used a CRISPR screen in lab-grown microglia to find which genes ten risk spots affect. The work points to microglia as a key site where gene risk acts.
Catalog record
| CREATOR | Michael D Gallagher, Wenjuan Du, Katheryn EA Hazel, Zeynep Aydin, Yiran Cheng, Bingbing Yuan, George W Bell, Richard A Young, Rudolf Jaenisch, Olivia Corradin |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 3 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |